case_images: PMC7649882_01
case_images: EGD. Endoscopic visualization of the esophageal mass (arrow) in the middle one-third of the esophagus.
case_images: 10.1177_2036361320972218-fig1.jpg
case_images: PMC7649882_01_10.1177_2036361320972218-fig1.jpg
case_images: fig1-2036361320972218
case_images: The tumor was 5.5 cm in diameter and 10 cm in length (Figure 1).
case_images: CT chest (axial view). Large esophageal mass (arrow) with infiltration of the mediastinum.
case_images: 10.1177_2036361320972218-fig2.jpg
case_images: PMC7649882_01_10.1177_2036361320972218-fig2.jpg
case_images: fig2-2036361320972218
case_images: A staging positron emission tomography with computed tomography (PET/CT) scan revealed irregular thickening of the middle-third of the esophagus, consistent with esophageal mass seen on endoscopy (Figure 2).
case_images: PET/CT (coronal view): (a) intense fluorodeoxyglucose uptake in the region of the esophageal mass (arrow) and (b) complete resolution of fluorodeoxyglucose uptake in esophagus.
case_images: 10.1177_2036361320972218-fig3.jpg
case_images: PMC7649882_01_10.1177_2036361320972218-fig3.jpg
case_images: fig3-2036361320972218
case_images: Response to therapy as assessed by PET/CT showed a marked response to therapy with no definite residual FDG uptake within the esophagus (Figure 3).